Media Hub

May 2017

New prostate cancer test could reduce biopsies by 50 per cent

The current method of testing for prostate cancer is fairly unreliable. It frequently produces inaccurate results that can result in patients undergoing unnecessary surgery, putting them at risk of erectile dysfunction or urinary incontinence. However, according to researchers, a new blood test, known as IsoPSA, has been shown to detect the cancer more precisely. The new…

Read More